TGA approval is 2 years away, that is why the pivot into CE approval to gain access into the bigger IVF markets of Europe, you can check this against last presentation.
Complete Monash trial data analysis ASAP, then push for CE registration, Vitrolife hopefully steps up in Japan? and China clinical trials presently underway.
3 key drivers for next 6 months to look for along with RoXsta !
EXCITING 2025 if/when share starts to move?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(10.0%) |
Mkt cap ! $8.926M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $4.095K | 961.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 6110023 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 4914915 | 11 |
View Market Depth
| Last trade - 15.40pm 24/06/2025 (20 minute delay) ? |
| MEM (ASX) Chart |